keyword
https://read.qxmd.com/read/35728381/comparison-of-adjuvant-pharmaceuticals-for-caudal-block-in-pediatric-lower-abdominal-and-urological-surgeries-a-network-meta-analysis
#21
REVIEW
Chang Xiong, Chengpeng Han, Huayan Lv, Duojia Xu, Wenyong Peng, Dong Zhao, Zhijian Lan
STUDY OBJECTIVE: Caudal block helps relieve pain after sub-umbilical surgery in pediatric patients; however, the duration for which it exerts its analgesic effect is limited. The addition of certain adjuvant agents to local anesthetics (LAs) that are used to administer caudal block can prolong postoperative analgesia. Therefore, we aimed to compare the efficiencies and side effects of caudal adjuvants in the settings of pediatric lower abdominal and urological surgeries. DESIGN: A network meta-analysis (NMA)...
October 2022: Journal of Clinical Anesthesia
https://read.qxmd.com/read/35718395/nonopioid-postoperative-pain-management-in-neurosurgery
#22
REVIEW
Nathan A Shlobin, Joshua M Rosenow
Neurosurgeons have sought to minimize the use of opioids in neurosurgery. Preoperative medical strategies include methadone and gabapentinoids. Intraoperative strategies include local anesthetic infiltration with bupivacaine, ropivacaine, and lidocaine; scalp block; steroids such as methylprednisolone, triamcinolone, and dexamethasone; ketamine; acetaminophen; ketorolac; liposomal bupivacaine; dexmedetomidine; and performing awake surgery. Postoperative strategies include continuous infusion pumps, wound catheters, and patient-controlled analgesia...
July 2022: Neurosurgery Clinics of North America
https://read.qxmd.com/read/35645354/alternative-options-for-complex-recurrent-pain-states-using-cannabinoids-psilocybin-and-ketamine-a-narrative-review-of-clinical-evidence
#23
REVIEW
Amber N Edinoff, Juliana M Fort, Christina Singh, Sarah E Wagner, Jessica R Rodriguez, Catherine A Johnson, Elyse M Cornett, Kevin S Murnane, Adam M Kaye, Alan D Kaye
With emerging information about the potential for morbidity and reduced life expectancy with long-term use of opioids, it is logical to evaluate nonopioid analgesic treatments to manage pain states. Combinations of drugs can provide additive and/or synergistic effects that can benefit the management of pain states. In this regard, tetrahydrocannabinol (THC) and cannabidiol (CBD) modulate nociceptive signals and have been studied for chronic pain treatment. Psilocybin, commonly known as "magic mushrooms", works at the serotonin receptor, 5-HT2A ...
May 18, 2022: Neurology International
https://read.qxmd.com/read/35386408/comparative-efficacy-and-safety-of-11-drugs-as-therapies-for-adults-with-neuropathic-pain-after-spinal-cord-injury-a-bayesian-network-analysis-based-on-20-randomized-controlled-trials
#24
Hai-Qian Ling, Zi-Hao Chen, Lei He, Feng Feng, Chuang-Gui Weng, Si-Jin Cheng, Li-Min Rong, Pei-Gen Xie
Objective: To provide an updated analysis of the efficacy and safety of drugs for the management of neuropathic pain (NP) after spinal cord injury (SCI) based on Bayesian network analysis. Methods: A Bayesian network meta-analysis of literature searches within PubMed, Cochrane Library, Embase, and Web of Science databases from their inception to February 21 2021 was conducted without language restrictions. Paired and network meta-analyses of random effects were used to estimate the total standardized mean deviations (SMDs) and odds ratios (ORs)...
2022: Frontiers in Neurology
https://read.qxmd.com/read/35356451/intravenous-lidocaine-and-ketamine-infusions-for-headache-disorders-a-retrospective-cohort-study
#25
JOURNAL ARTICLE
Jason C Ray, Shuli Cheng, Kirsten Tsan, Hassan Hussain, Richard J Stark, Manjit S Matharu, Elspeth Hutton
INTRODUCTION: The use of lidocaine (lignocaine) and ketamine infusion in the inpatient treatment of patients with headache disorders is supported by small case series. We undertook a retrospective cohort study in order to assess the efficacy, duration and safety of lidocaine and ketamine infusions. METHODS: Patients admitted between 01/01/2018 and 31/07/2021 were identified by ICD code and electronic prescription. Efficacy of infusion was determined by reduction in visual analog score (VAS), and patient demographics were collected from review of the hospital electronic medical record...
2022: Frontiers in Neurology
https://read.qxmd.com/read/35092901/ketamine-as-a-therapeutic-agent-for-depression-and-pain-mechanisms-and-evidence
#26
JOURNAL ARTICLE
Subha Subramanian, Simon Haroutounian, Ben Julian A Palanca, Eric J Lenze
Ketamine is an anesthetic drug which is now used to treat chronic pain conditions and psychiatric disorders, especially depression. It is an N-methyl-D-aspartate (NMDA) receptor antagonist with additional effects on α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, opioid receptors, and monoaminergic receptors. This article focuses on ketamine's role in treating depression and pain, two commonly comorbid challenging conditions with potentially shared neurobiologic circuitry...
March 15, 2022: Journal of the Neurological Sciences
https://read.qxmd.com/read/34922987/beating-pain-with-psychedelics-matter-over-mind
#27
REVIEW
Igor Elman, Amanda Pustilnik, David Borsook
Basic pain research has shed light on key cellular and molecular mechanisms underlying nociceptive and phenomenological aspects of pain. Despite these advances, we still yearn for the discovery of novel therapeutic strategies to address the unmet needs of about 70 % of chronic neuropathic pain patients whose pain fails to respond to opioids as well as to other conventional analgesic agents. Importantly, a substantial body of clinical observations over the past decade cumulatively suggests that the psychedelic class of drugs may possess heuristic value for understanding and treating chronic pain conditions...
March 2022: Neuroscience and Biobehavioral Reviews
https://read.qxmd.com/read/34872428/multimodal-analgesia-in-neurosurgery-a-narrative-review
#28
REVIEW
Caterina Aurilio, Maria Caterina Pace, Pasquale Sansone, Luca Gregorio Giaccari, Francesco Coppolino, Vincenzo Pota, Manlio Barbarisi
Pain following brain surgery can compromise the result of surgery. Several pharmacological interventions have been used to prevent postoperative pain in adults undergoing brain surgery. Pain following craniotomy is considered to be moderate to severe during the first two post-operative days. Opioids have been historically the mainstay and are the current prominent strategy for pain treatment. They produce analgesia but may alter respiratory, cardiovascular, gastrointestinal, and neuroendocrine functions. All these side effects may affect the normal postoperative course of craniotomy by affecting neurological function and increasing intracranial pressure...
April 2022: Postgraduate Medicine
https://read.qxmd.com/read/34620069/comparing-the-efficacy-and-safety-of-dexmedetomidine-ketamine-with-propofol-fentanyl-for-sedation-in-colonoscopy-patients-a-doubleblinded-randomized-clinical-trial
#29
RANDOMIZED CONTROLLED TRIAL
Reza Aminnejad, Ahmad Hormati, Hamed Shafiee, Faezeh Alemi, Maryam Hormati, Mohammad Saeidi, Sajjad Ahmadpour, Seyed Mahdi Sabouri, Mohammad Aghaali
BACKGROUND: In this double-blinded randomized clinical trial, we aimed to compare the safety and efficacy of a combination of Dexmedetomidine and Ketamine (DK) with Propofol and Fentanyl (PF) for sedation in colonoscopy patients. METHODS: In this study, 64 patients who underwent colonoscopy were randomized into two groups: 1) A, which received PF, and 2) B, which received DK for sedation. Among 64 patients, 31 patients were included in PF, and 33 patients were included in the DK group...
2022: CNS & Neurological Disorders Drug Targets
https://read.qxmd.com/read/34568362/effects-of-esketamine-on-acute-and-chronic-pain-after-thoracoscopy-pulmonary-surgery-under-general-anesthesia-a-multicenter-prospective-randomized-double-blind-and-controlled-trial
#30
JOURNAL ARTICLE
Yishan Lei, Huayue Liu, Fan Xia, Shulin Gan, Yulan Wang, Wenwen Huo, Qinyun Wang, Fuhai Ji
Background: Post-operative pain management for patients undergoing thoracoscopy surgery is challenging for clinicians which increase both health and economic burden. The non-selective NMDA receptor antagonist esketamine possesses an analgesic effect twice that of ketamine. The application of esketamine might be beneficial in alleviating acute and chronic pain after thoracic surgery. The current study describes the protocol aiming to evaluate the analgesic effect of esketamine after pulmonary surgery via visual analog scale (VAS) score for acute and chronic pain...
2021: Frontiers in Medicine
https://read.qxmd.com/read/34084620/effects-of-ketamine-versus-dexmedetomidine-maintenance-infusion-in-posterior-spinal-fusion-surgery-on-acute-postoperative-pain
#31
JOURNAL ARTICLE
Nasim Nikoubakht, Mahzad Alimian, Seyed Hamid Reza Faiz, Pooya Derakhshan, Mohammad Saleh Sadri
BACKGROUND: One of the most challenging issues after posterior spinal fusion (PSF) surgery is providing appropriate pain control measures to enhance recovery of the patients. We aimed to compare effects of ketamine versus dexmedetomidine infusion during maintenance of anesthesia on acute postoperative pain in PSF surgery. METHODS: In a double-blinded randomized clinical trial, 87 patients candidates for PSF surgery were randomly assigned into three groups. Anesthesia protocol for all groups was the same except: the first group received 0...
2021: Surgical Neurology International
https://read.qxmd.com/read/33490941/complex-regional-pain-syndrome-autoimmune-or-functional-neurologic-syndrome
#32
REVIEW
Christopher Chang, Patrick McDonnell, M Eric Gershwin
Complex regional pain syndrome (CRPS) purports to explain extremity pain accompanied by a variety of subjective complaints, including sensitivity to touch, fatigue, burning sensations, allodynia and signs consistent with voluntary immobilization, including skin changes, edema and trophic changes. By its own definition, CRPS pain is disproportionate to any inciting event or underlying pathology, which means that the syndrome describes non-anatomic and exaggerated symptoms. Although CRPS was coined in the early 1990s, physicians have described unexplained exaggerated pain for centuries...
2021: Journal of translational autoimmunity
https://read.qxmd.com/read/33475079/interactions-between-ketamine-and-magnesium-for-the-treatment-of-pain-current-state-of-the-art
#33
REVIEW
Katarina S Vujović, Sonja Vučković, Radan Stojanović, Nevena Divac, Branislava Medić, Aleksandar Vujović, Dragana Srebro, Milica Prostran
BACKGROUND: Over the past three decades, NMDA-receptor antagonists have been shown to be efficient drugs for treating pain, particularly pain resistant to conventional analgesics. Emphasis will be on the old-new drugs, ketamine and magnesium, and their combination as a novel approach for treating chronic pain. METHODS: The MEDLINE database was searched via PubMed for articles that were published up to March 1, 2020, with the keywords 'ketamine', 'magnesium', and 'pain' (in the title/abstract)...
2021: CNS & Neurological Disorders Drug Targets
https://read.qxmd.com/read/33431538/management-of-refractory-pain-in-stiff-person-syndrome
#34
JOURNAL ARTICLE
Frank Arthur Cirnigliaro, Nicole Gauthier, Moira Rush
Stiff-Person syndrome (SPS) is a rare autoimmune neurological disorder characterised by episodic painful muscle rigidity and violent spasms. A significant trigger for the painful spasms experienced by patients is pain itself, making optimal pain management and avoidance a necessity. While first-line and second-line therapies for spasm prevention and termination are known, there is a paucity of evidence to guide pain management. We report the case of a 26-year-old woman with SPS referred for excruciating muscle cramping and rigidity with pain lasting beyond the episodes themselves...
January 11, 2021: BMJ Case Reports
https://read.qxmd.com/read/33386430/working-memory-associated-with-anti-suicidal-ideation-effect-of-repeated-dose-intravenous-ketamine-in-depressed-patients
#35
JOURNAL ARTICLE
Xiaoyu Chen, Mingqia Wang, Yiru Hu, Yanni Zhan, Yanling Zhou, Wei Zheng, Weijian Liu, Chengyu Wang, Xiaomei Zhong, Hanqiu Li, Xiaofeng Lan, Yuping Ning, Bin Zhang
Suicide is a tremendous threat to global public health, and a large number of people who committed suicide suffered the pain of mental diseases, especially major depressive disorder (MDD). Previous study showed that ketamine could reduce suicidal ideation (SI), potentially by improving the impaired working memory (WM). The objective of current study was to illuminate the relationship between WM and SI in MDD with repeated ketamine treatment. MDD patients with SI (n = 59) and without SI (n = 37) completed six intravenous infusions of ketamine (0...
January 1, 2021: European Archives of Psychiatry and Clinical Neuroscience
https://read.qxmd.com/read/33128439/a-review-of-the-clinical-applications-of-ketamine-in-pediatric-oncology
#36
REVIEW
Satya Prakash, Aditya Kumar Gupta, Jagdish Prasad Meena, Rachna Seth
Ketamine is a dissociative anesthetic agent with excellent analgesic properties and a favorable safety profile. The feasibility and efficacy of various routes of administration have been established, including intravenous (IV), intramuscular (IM), oral, intranasal, rectal, and transdermal routes. The advent of newer anesthetic agents has led to a decline in the use of ketamine as an anesthetic, but its utility in short-term sedation and analgesia has expanded. Its value for chronic pain management in children with cancer is being increasingly recognized but requires more evidence...
January 2021: Pediatric Blood & Cancer
https://read.qxmd.com/read/32953182/physiologically-difficult-airway-in-the-patient-with-severe-hypotension-and-metabolic-acidosis
#37
Joseph Capone, Vicko Gluncic, Anita Lukic, Kenneth D Candido
The expertise to recognize and manage the difficult airway is essential in anesthesiology. Conventionally, this refers to anatomical concerns causing difficulties with facemask ventilation and/or with tracheal intubation. Severe derangements in patients' physiology can make induction and intubation likewise difficult, and approximately 30% of critically ill patients had cardiovascular collapse subsequently to intubation. We present the case of a 58-year-old male with a past medical history of type II diabetes and hypertension who presented with altered mental status due to severe metabolic acidosis with a pH of 6...
2020: Case Reports in Anesthesiology
https://read.qxmd.com/read/32420713/epidural-anesthesia-is-no-longer-the-standard-of-care-in-abdominal-surgery-with-eras-what-are-the-alternatives
#38
JOURNAL ARTICLE
Michel F Wagemans, Willem K Scholten, Markus W Hollmann, Antonius H Kuipers
Epidural anesthesia has been considered the gold standard for perioperative analgesia, but the implementation of enhanced recovery after surgery (ERAS) protocols and a shift from open to laparoscopic surgery have diminished the advantage of epidural anesthesia. The authors summarize data from two newer meta-analyses and discuss the consequences for the role of epidural anesthesia (EA) in the perioperative setting. These meta-analyses enabled to distinguish between pre- and post-ERAS outcomes. Endpoints related to open and laparoscopic abdominal surgery were retrieved...
October 2020: Minerva Anestesiologica
https://read.qxmd.com/read/32384914/propofol-versus-placebo-with-rescue-with-ketamine-before-less-invasive-surfactant-administration-study-protocol-for-a-multicenter-double-blind-placebo-controlled-trial-prolisa
#39
JOURNAL ARTICLE
Marie Chevallier, Xavier Durrmeyer, Anne Ego, Thierry Debillon
BACKGROUND: One major limitation for less invasive surfactant administration (LISA) is the difficulty in providing sedation before this procedure and the competitive risk of respiratory depression versus avoidance of intubation for most sedative or analgesic drugs used in this context. The objective of this study is to compare the need for mechanical ventilation within 72 h of life following premedication with propofol, versus placebo (rescue with ketamine), for the LISA procedure in preterm neonates born before 32 weeks gestational age (wGA)...
May 8, 2020: BMC Pediatrics
https://read.qxmd.com/read/32308676/a-review-of-nonanesthetic-uses-of-ketamine
#40
REVIEW
Abby Pribish, Nicole Wood, Arun Kalava
Ketamine, a nonselective NMDA receptor antagonist, is used widely in medicine as an anesthetic agent. However, ketamine's mechanisms of action lead to widespread physiological effects, some of which are now coming to the forefront of research for the treatment of diverse medical disorders. This paper aims at reviewing recent data on key nonanesthetic uses of ketamine in the current literature. MEDLINE, CINAHL, and Google Scholar databases were queried to find articles related to ketamine in the treatment of depression, pain syndromes including acute pain, chronic pain, and headache, neurologic applications including neuroprotection and seizures, and alcohol and substance use disorders...
2020: Anesthesiology Research and Practice
keyword
keyword
50850
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.